Patent details
EP3692983 Title: ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
Basic Information
- Publication number:
- EP3692983
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP192131480
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
- French Title of Invention:
- FORMULATIONS ORALES D'ANALOGUES DE CYTIDINE ET LEURS PROCÉDÉS D'UTILISATION
- German Title of Invention:
- ORALE FORMULIERUNGEN VON CYTIDINANALOGA UND VERFAHREN ZUR VERWENDUNG DAVON
- SPC Number:
Dates
- Filing date:
- 14/05/2009
- Grant date:
- 11/08/2021
- EP Publication Date:
- 12/08/2020
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/08/2021
- EP B1 Publication Date:
- 11/08/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 14/05/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/03/2024
- Name:
- Celgene Corporation
- Address:
- Route 206 & Province Line Road, Princeton, NJ 08543, United States (US)
History of Owners
- From:
- 04/08/2021
- To:
- 01/03/2024
- Name:
- Celgene Corporation
- Address:
- 86 Morris Avenue, Summit, NJ 07901, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 19/08/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- ETTER, Jeffrey B
- Address:
- United States (US)
2
- Name:
- BACKSTROM, Jay T
- Address:
- United States (US)
3
- Name:
- LAI, Mei
- Address:
- United States (US)
Priority
1
- Priority Number:
- 5360908 P
- Priority Date:
- 15/05/2008
- Priority Country:
- United States (US)
2
- Priority Number:
- 20114508 P
- Priority Date:
- 05/12/2008
- Priority Country:
- United States (US)
3
- Priority Number:
- 15787509 P
- Priority Date:
- 05/03/2009
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61P 1/00; A61K 9/20; A61K 9/28; A61K 31/7068; A61P 1/18; A61P 15/08; A61P 35/00; A61P 35/02; A61P 43/00; A61K 47/26;
Publication
European Patent Bulletin
1
- Issue number:
- 202132
- Publication date:
- 11/08/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202223
- Publication date:
- 08/06/2022
- Description:
- Opposition procedure started
3
- Issue number:
- 202414
- Publication date:
- 03/04/2024
- Description:
- Change of owner's name or address
Annual Fees
- Annual Fee Due Date:
- 02/06/2025
- Annual Fee Number:
- 17
- Annual Fee Amount:
- 246 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 26/04/2024
- Last Annual Fee Paid Number:
- 16
- Last Annual Fee Paid Amount:
- 230 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 19/08/2021 | Outgoing Correspondence | 1 |
| 19/08/2021 | Power Of Attorney | 1 |